RNA-Targeted Drug Discovery Summit 2018
In-Person Event
Dec 03 - 05, 2018
Boston, Massachusetts, USA
OVERVIEW
RNA-Targeted Drug Discovery Summit is organized by Hanson Wade and will be held from Dec 03 - 05, 2018 at DoubleTree Suites by Hilton Hotel Boston - Cambridge, Boston, Massachusetts, United States of America.
Description:
With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up.
The 1st RNA-Targeted Drug Discovery Summit will bring together a unique community of experts, devoted to optimizing the process of discovering and designing small molecules that bind specifically to quality RNA targets and translating these into clinically safe and effective therapies.
Meet with experts and come away with:
• Deep understanding of how to translate the structure, dynamics and function of RNA into lead small molecules with insights from Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute. Explore experimental approaches that support target engagement in cells to support compound mode of action.
• Explore the discovery, structure and cellular activity of small molecule inhibitors of cellular and viral RNAs through the insights delivered by Gabriele Varani, Professor of Chemistry, University of Washington.
• Understand principles for targeting RNA with small molecules with perspectives from Kevin Weeks, Professor, UNC to help structure your research into targeting RNA
Speakers:
Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute, Kevin Weeks, Professor, UNC, Matt Woll, Senior Director of Chemistry, PTC Therapeutics, Anne Boriack-Sjodin, VP of Molecular Discovery, Accent Therapeutics, Razvan Nutiu, Investigator III, Novartis , Benjamin Miller, Principal Investigator, URMC, Jennifer Petter, Founder & CSO, Arrakis Therapeutics, Gabriele Varani, Professor of Chemistry, University of Washington
Additional details will be posted as soon as they are available.
Description:
With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up.
The 1st RNA-Targeted Drug Discovery Summit will bring together a unique community of experts, devoted to optimizing the process of discovering and designing small molecules that bind specifically to quality RNA targets and translating these into clinically safe and effective therapies.
Meet with experts and come away with:
• Deep understanding of how to translate the structure, dynamics and function of RNA into lead small molecules with insights from Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute. Explore experimental approaches that support target engagement in cells to support compound mode of action.
• Explore the discovery, structure and cellular activity of small molecule inhibitors of cellular and viral RNAs through the insights delivered by Gabriele Varani, Professor of Chemistry, University of Washington.
• Understand principles for targeting RNA with small molecules with perspectives from Kevin Weeks, Professor, UNC to help structure your research into targeting RNA
Speakers:
Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute, Kevin Weeks, Professor, UNC, Matt Woll, Senior Director of Chemistry, PTC Therapeutics, Anne Boriack-Sjodin, VP of Molecular Discovery, Accent Therapeutics, Razvan Nutiu, Investigator III, Novartis , Benjamin Miller, Principal Investigator, URMC, Jennifer Petter, Founder & CSO, Arrakis Therapeutics, Gabriele Varani, Professor of Chemistry, University of Washington
Additional details will be posted as soon as they are available.
KEY DATES
03 Dec, 2018
Event Start Date
05 Dec, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
DoubleTree Suites by Hilton Hotel Boston - CambridgeRELATED CONFERENCES & LIVE WEBINARS
Quick Links